Schedule 13G ownership disclosure

NEXUS BIOPHARMA INC

Security class unavailable · CUSIP: 65341U104

Event date: 2016-06-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,192,980
Percent of class
11.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001078782-16-003083
Form type
SC 13G
Filer
CROCUS BAY VENTURES LLC
CIK
CIK 1678981
Filed
Jul 08, 2016
Reporting period
Jun 09, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub